Demant AS Valuation
WILYY Stock | USD 18.86 0.00 0.00% |
At this time, the firm appears to be overvalued. Demant AS ADR shows a prevailing Real Value of $15.47 per share. The current price of the firm is $18.86. Our model computes the value of Demant AS ADR from reviewing the firm fundamentals such as Profit Margin of 0.11 %, current valuation of 8.18 B, and Shares Outstanding of 446.37 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Demant AS's price fluctuation is very steady at this time. Calculation of the real value of Demant AS ADR is based on 3 months time horizon. Increasing Demant AS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Demant AS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Demant Pink Sheet. However, Demant AS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 18.86 | Real 15.47 | Hype 18.86 | Naive 19.06 |
The intrinsic value of Demant AS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Demant AS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Demant AS ADR helps investors to forecast how Demant pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Demant AS more accurately as focusing exclusively on Demant AS's fundamentals will not take into account other important factors: Demant AS Total Value Analysis
Demant AS ADR is at this time anticipated to have takeover price of 8.18 B with market capitalization of 7.02 B, debt of 6.1 B, and cash on hands of 1.24 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Demant AS fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
8.18 B | 7.02 B | 6.1 B | 1.24 B |
Demant AS Investor Information
The company has Price/Earnings To Growth (PEG) ratio of 1.72. Demant AS ADR had not issued any dividends in recent years. The entity had 2:1 split on the 14th of June 2016. Based on the key indicators related to Demant AS's liquidity, profitability, solvency, and operating efficiency, Demant AS ADR is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Demant AS Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Demant AS has an asset utilization ratio of 66.0 percent. This suggests that the Company is making $0.66 for each dollar of assets. An increasing asset utilization means that Demant AS ADR is more efficient with each dollar of assets it utilizes for everyday operations.Demant AS Profitability Analysis
The company reported the revenue of 19.7 B. Net Income was 2.08 B with profit before overhead, payroll, taxes, and interest of 14.67 B.About Demant AS Valuation
Our relative valuation model uses a comparative analysis of Demant AS. We calculate exposure to Demant AS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Demant AS's related companies.Demant AS, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. Demant As is traded on OTC Exchange in the United States.
8 Steps to conduct Demant AS's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Demant AS's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Demant AS's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Demant AS's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Demant AS's revenue streams: Identify Demant AS's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Demant AS's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Demant AS's growth potential: Evaluate Demant AS's management, business model, and growth potential.
- Determine Demant AS's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Demant AS's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Demant AS Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 223.2 M | |
Quarterly Earnings Growth Y O Y | -0.201 | |
Forward Price Earnings | 15.9744 | |
Retained Earnings | 8.4 B |
Additional Tools for Demant Pink Sheet Analysis
When running Demant AS's price analysis, check to measure Demant AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Demant AS is operating at the current time. Most of Demant AS's value examination focuses on studying past and present price action to predict the probability of Demant AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Demant AS's price. Additionally, you may evaluate how the addition of Demant AS to your portfolios can decrease your overall portfolio volatility.